Calcitriol supplementation in PAN-NS prevented cardiac hypertrophy, fibrosis, and inflammation, namely, by downregulating ET-1a, TGF-β1, and TNF-α genes and protein expression. The gene discussed is TGFB1; the disease is cardiac hypertrophy.